Betatrophin has recently emerged as an indicator of metabolic disorders, with two separate case-control studies finding that betatrophin levels are ﻿elevated in subjects with metabolic syndrome and hypertension [31, 32]. This evidence concerns the gene ANGPTL8 and hypertensive disorder.